West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Michel Lagarde
CEOMichel Lagarde
Employees
10,800
Employees10,800
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,800
Employees10,800

WST Key Statistics

Market cap
26.28B
Market cap26.28B
Price-Earnings ratio
48.05
Price-Earnings ratio48.05
Dividend yield
0.23%
Dividend yield0.23%
Average volume
747.34K
Average volume747.34K
High today
$382.71
High today$382.71
Low today
$370.71
Low today$370.71
Open price
$373.35
Open price$373.35
Volume
707.80K
Volume707.80K
52 Week high
$386.00
52 Week high$386.00
52 Week low
$223.83
52 Week low$223.83

Stock Snapshot

West Pharmaceutical Services(WST) stock is priced at $373.60, giving the company a market capitalization of 26.28B. It carries a P/E multiple of 48.05 and pays a dividend yield of 0.23%.

During the trading session on 2026-09-24, West Pharmaceutical Services(WST) shares reached a daily high of $382.71 and a low of $370.71. At a current price of $373.60, the stock is +0.8% higher than the low and still -2.4% under the high.

Trading activity shows a volume of 707.8K, compared to an average daily volume of 747.34K.

Over the past 52 weeks, West Pharmaceutical Services(WST) stock has traded between a high of $386.00 and a low of $223.83.

Over the past 52 weeks, West Pharmaceutical Services(WST) stock has traded between a high of $386.00 and a low of $223.83.

WST News

MarketWatch 2d
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

...

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
TipRanks 2d
West Pharmaceutical upgraded to Overweight at Morgan Stanley on durable growth

As previously reported, Morgan Stanley analyst Kallum Titchmarsh upgraded West Pharmaceutical (WST) to Overweight from Equal Weight with a price target of $400,...

Simply Wall St 5d
West Pharmaceutical Services Could Be 10% Undervalued On GLP 1 And Annex 1 Demand

Advertisement West Pharmaceutical Services event puts growth drivers and risks in sharper focus West Pharmaceutical Services (WST) is back in the spotlight af...

West Pharmaceutical Services Could Be 10% Undervalued On GLP 1 And Annex 1 Demand

Analyst ratings

95%

of 20 ratings
Buy
95%
Hold
5%
Sell
0%

More WST News

Simply Wall St 6d
How Annex 1 Upgrades At West Pharmaceutical Services Have Changed Its Investment Story

West Pharmaceutical Services is reported to be well positioned for growth, supported by demand for high-value components, expanding biologics exposure, and regu...

How Annex 1 Upgrades At West Pharmaceutical Services Have Changed Its Investment Story

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.